CPhI Worldwide – organized by UBM (part of Informa PLC) – has announced the opening of the 2018 CPhI Pharma Awards for entries. The industry’s preeminent awards return for a landmark 15th edition, with 17 categories honouring companies and individuals driving the pharma industry forward through innovations, technologies, and strategies. This year's categories include: â Excellence in Pharma: CEO of the Year â Excellence in Pharma: Supply Chain, Logistics, and Distribution â Excellence in Pharma: Contract Services and Outsourcing â Excellence in Pharma: Regulatory Procedures and Compliance â Excellence in Pharma: Corporate Social Responsibility â Excellence in Pharma: Pharma Company of the Year â Excellence in Pharma: OTC â Excellence in Pharma: Patient Centricity â Excellence in Pharma: IT, mHealth & Digitalisation Last year, the awards received a record number of submissions (over 200 applications). CPhI Worldwide is expecting greater interest in 2018. Former winners of the CEO of the year award include Vivek Sharma, CEO of Piramal (winner in 2015); Udit Batra, CEO of Merck (winner in 2016), and last year Richard Chin, MD, founder and CEO of Kindred Biosciences. Another increasingly significant category is the Corporate Social Responsibility award, which will be given in partnership with official charity partner, International Medical Corps. Orhan Caglayan, Brand Director – CPhI Worldwide, UBM (part of Informa PLC), commented: “The awards are now rightly lauded as the most prestigious in pharma. If you or your company want to be recognized amongst the industry and your peers as driving forward developments, we encourage you to take part – all pharma and supply chain companies are welcome.” Submitting your entry(ies) for the CPhI Pharma Awards is free of charge and the deadline is July 31, 2018 – with shortlisted finalists announced August 28, 2018. The winners will be unveiled during a ceremony at the prestigious Eurostars Madrid Tower in Madrid, on October 9th during the evening of the first day of CPhI Worldwide. To apply please visit https://awards.cphi.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.